Phenethyl isothiocyanate suppresses inhibitor of apoptosis family protein expression in prostate cancer cells in culture and in vivo

Prostate

Volumn 72, Issue 10, 2012, Pages 1104-1116

  Sakao, Kozue ^a   Desineni, Sudhakar ^a   Hahm, Eun Ryeong ^a   Singh, Shivendra V ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

chemoprevention; phenethyl isothiocyanate; Survivin; XIAP

Indexed keywords

DNA FRAGMENT; HISTONE; INHIBITOR OF APOPTOSIS PROTEIN; MESSENGER RNA; PHENETHYL ISOTHIOCYANATE; SURVIVIN; TRYPAN BLUE; X LINKED INHIBITOR OF APOPTOSIS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CELL MIGRATION; CELL STRAIN LNCAP; CELL VIABILITY; CONTROLLED STUDY; CYTOSOL; DOWN REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSIENT TRANSFECTION; WESTERN BLOTTING;

ANIMALS; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; ISOTHIOCYANATES; MALE; MICE; MICE, TRANSGENIC; PROSTATIC NEOPLASMS;

EID: 84861570467     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.22457     Document Type: Article

References (48)

1. Surh YJ,. Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 2003; 3 (10): 768-780.
2. Stan SD, Kar S, Stoner GD, Singh SV,. Bioactive food components and cancer risk reduction. J Cell Biochem 2008; 104 (1): 339-356.
3. Powolny AA, Singh SV,. Multitargeted prevention and therapy of cancer by diallyl trisulfide and related Allium vegetable-derived organosulfur compounds. Cancer Lett 2008; 269 (2): 305-314.
4. Jemal A, Siegel R, Xu J, Ward E,. Cancer Statistics, 2010. CA Cancer J Clin 2010; 60 (5): 277-300.
5. Hecht SS,. Inhibition of carcinogenesis by isothiocyanates. Drug Metab Rev 2000; 32 (3-4): 395-411.
6. Cheung KL, Kong AN,. Molecular targets of dietary phenethyl isothiocyanate and sulforaphane for cancer chemoprevention. AAPS J 2010; 12 (1): 87-97.
7. Fahey JW, Zalcmann AT, Talalay P,. The chemical diversity and distribution of glucosinolates and isothiocyanates among plants. Phytochemistry 2001; 56 (1): 5-51.
8. Kolonel LN, Hankin JH, Whittemore AS, Wu AH, Gallagher RP, Wilkens LR, John EM, Howe GR, Dreon DM, West DW,., Paffenbarger RS Jr., Vegetables, fruits, legumes and prostate cancer: A multiethnic case-control study. Cancer Epidemiol Biomarkers Prev 2000; 9 (8): 795-804.
9. Cohen JH, Kristal AR, Stanford JL,. Fruit and vegetable intakes and prostate cancer risk. J Natl Cancer Inst 2000; 92 (1): 61-68.
10. Barve A, Khor TO, Hao X, Keum YS, Yang CS, Reddy B, Kong AN,. Murine prostate cancer inhibition by dietary phytochemicals-curcumin and phenyethylisothiocyanate. Pharm Res 2008; 25 (9): 2181-2189.
11. Powolny AA, Bommareddy A, Hahm ER, Normolle DP, Beumer JH, Nelson JB, Singh SV,. Chemopreventative potential of the cruciferous vegetable constituent phenethyl isothiocyanate in a mouse model of prostate cancer. J Natl Cancer Inst 2011; 103 (7): 571-584.
12. Xiao D, Lew KL, Zeng Y, Xiao H, Marynowski SW, Dhir R, Singh SV,. Phenethyl isothiocyanate-induced apoptosis in PC-3 human prostate cancer cells is mediated by reactive oxygen species-dependent disruption of the mitochondrial membrane potential. Carcinogenesis 2006; 27 (11): 2223-2234.
13. Xiao D, Zeng Y, Choi S, Lew KL, Nelson JB, Singh SV,. Caspase-dependent apoptosis induction by phenethyl isothiocyanate, a cruciferous vegetable-derived cancer chemopreventive agent, is mediated by Bak and Bax. Clin Cancer Res 2005; 11 (7): 2670-2679.
14. Xiao D, Singh SV,. Phenethyl isothiocyanate sensitizes androgen-independent human prostate cancer cells to docetaxel-induced apoptosis in vitro and in vivo. Pharm Res 2010; 27 (4): 722-731.
15. Chiao JW, Wu H, Ramaswamy G, Conaway CC, Chung FL, Wang L, Liu D,. Ingestion of an isothiocyanate metabolite from cruciferous vegetables inhibits growth of human prostate cancer cell xenografts by apoptosis and cell cycle arrest. Carcinogenesis 2004; 25 (8): 1403-1408.
16. Nelson WG, De Marzo AM, Isaacs WB,. Prostate cancer. N Engl J Med 2003; 349 (4): 366-381.
17. Xu C, Shen G, Chen C, Gélinas C, Kong AN,. Suppression of NF-κB and NF-κB-regulated gene expression by sulforaphane and PEITC through lκBα, IKK pathway in human prostate cancer PC-3cells. Oncogene 2005; 24 (28): 4486-4495.
18. Kim JH, Xu C, Keum YS, Reddy B, Conney A, Kong AN,. Inhibition of EGFR signaling in human prostate cancer PC-3cells by combination treatment with β-phenylethyl isothiocyanate and curcumin. Carcinogenesis 2006; 27 (3): 475-482.
19. Xiao D, Singh SV,. Phenethyl isothiocyanate inhibits angiogenesis in vitro and ex vivo. Cancer Res 2007; 67 (5): 2239-2246.
20. Gong A, He M, Krishna Vanaja D, Yin P, Karnes RJ, Young CY,. Phenethyl isothiocyanate inhibits STAT3 activation in prostate cancer cells. Mol Nutr Food Res 2009; 53 (7): 878-886.
21. Xiao D, Powolny AA, Moura MB, Kelley EE, Bommareddy A, Kim SH, Hahm ER, Normolle D, Van Houten B, Singh SV,. Phenethyl isothiocyanate inhibits oxidative phosphorylation to trigger reactive oxygen species-mediated death of human prostate cancer cells. J Biol Chem 2010; 285 (34): 26558-26569.
22. LaCasse EC, Baird S, Korneluk RG, MacKenzie AE,. The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene 1998; 17 (25): 3247-3259.
23. Deveraux QL, Reed JC,. IAP family proteins-suppressors of apoptosis. Genes Dev 1999; 13 (3): 239-252.
24. Srinivasula SM, Ashwell JD,. IAPs: What's in a name? Mol Cell 2008; 30 (2): 123-135.
25. Krajewska M, Krajewski S, Banares S, Huang X, Turner B, Bubendorf L, Kallioniemi OP, Shabaik A, Vitiello A, PeehI D, Gao GJ, Reed JC,. Elevated expression of inhibitor of apoptosis proteins in prostate cancer. Clin Cancer Res 2003; 9 (13): 4914-4925.
26. Berezovskaya O, Schimmer AD, Glinskii AB, Pinilla C, Hoffman RM, Reed JC, Glinsky GV,. Increased expression of apoptosis inhibitor protein XIAP contributes to anoikis resistance of circulating human prostate cancer metastasis precursor cells. Cancer Res 2005; 65 (6): 2378-2386.
27. Seligson DB, Hongo F, Huerta-Yepez S, Mizutani Y, Miki T, Yu H, Horvath S, Chia D, Goodglick L, Bonavida B,. Expression of X-linked inhibitor of apoptosis protein is a strong predictor of human prostate cancer recurrence. Clin Cancer Res 2007; 13 (20): 6056-6063.
28. Xiao D, Choi S, Johnson DE, Vogel VG, Johnson CS, Trump DL, Lee YJ, Singh SV,. Diallyl trisulfide-induced apoptosis in human prostate cancer cells involves c-Jun N-terminal kinase and extracellular-signal regulated kinase-mediated phosphorylation of Bcl-2. Oncogene 2004; 23 (33): 5594-5606.
29. Sehrawat A, Singh SV,. Benzyl isothiocyanate inhibits epithelial-mesenchymal transition in cultured and xenografted human breast cancer cells. Cancer Prev Res 2011; 4 (7): 1107-1117.
30. 2-M-phase cell cycle arrest in PC-3 human prostate cancer cells. Mol Cancer Ther 2004; 3 (5): 567-575.
31. Xiao D, Choi S, Lee YJ, Singh SV,. Role of mitogen-activated protein kinases in phenethyl isothiocyanate-induced apoptosis in human prostate cancer cells. Mol Carcinog 2005; 43 (3): 130-140.
32. Bommareddy A, Hahm ER, Xiao D, Powolny AA, Fisher AL, Jiang Y, Singh SV,. Atg5 regulates phenethyl isothiocyanate-induced autophagic and apoptotic cell death in human prostate cancer cells. Cancer Res 2009; 69 (8): 3704-3712.
33. Zhang M, Coen JJ, Suzuki Y, Siedow MR, Niemierko A, Khor LY, Pollack A, Zhang Y, Zietman AL, Shipley WU, Chakravarti A,. Survivin is a potential mediator of prostate cancer metastasis. Int J Radiat Oncol Biol Phys 2010; 78 (4): 1095-1103.
34. Stoner GD, Morrissey DT, Heur YH, Daniel EM, Galati AJ, Wagner SA,. Inhibitory effects of phenethyl isothiocyanate on N-nitrosobenzylmethylamine carcinogenesis in the rat esophagus. Cancer Res 1991; 51 (8): 2063-2068.
35. Jiao D, Eklind KI, Choi CI, Desai DH, Amin SG, Chung FL,. Structure-activity relationships of isothiocyanates as mechanism-based inhibitors of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis in A/J mice. Cancer Res 1994; 54 (16): 4327-4333.
36. Min/+ mice by phenethyl isothiocyanate (PEITC). Mol Carcinog 2008; 47 (5): 321-325.
37. Dubrez-Daloz L, Dupoux A, Cartier J,. IAPs: More than just inhibitors of apoptosis proteins. Cell Cycle 2008; 7 (8): 1036-1046.
38. Rothe M, Pan MG, Henzel WJ, Ayres TM, Goeddel DV,. The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell 1995; 83 (7): 1243-1252.
39. Dean EJ, Ranson M, Blackhall F, Dive C,. X-linked inhibitor of apoptosis protein as a therapeutic target. Expert Opin Ther Targets 2007; 11 (11): 1459-1471.
40. Tamm I, Kornblau SM, Segall H, Krajewski S, Welsh K, Kitada S, Scudiero DA, Tudor G, Qui YH, Monks A, Andreeff M, Reed JC,. Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias. Clin Cancer Res 2000; 6 (5): 1796-1803.
41. Li M, Song T, Yin ZF,., Na YQ,. XIAP as a prognostic marker of early recurrence of nonmuscular invasive bladder cancer. Chin Med J 2007; 120 (6): 469-473.
42. Yang Y, Fang S, Jensen JP, Weissman AM, Ashwell JD,. Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli. Science 2000; 288 (5467): 874-877.
43. Galbán S, Duckett CS,. XIAP as a ubiquitin ligase in cellular signaling. Cell Death Differ 2010; 17 (1): 54-60.
44. Gu L, Zhu N, Zhang H, Durden DL, Feng Y, Zhou M,. Regulation of XIAP translation and induction by MDM2 following irradiation. Cancer Cell 2009; 15 (5): 363-375.
45. Altieri DC,. The case for survivin as a regulator of microtubule dynamics and cell-death decisions. Curr Opin Cell Biol 2006; 18 (6): 609-615.
46. Ambrosini G, Adida C, Altieri DC,. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 1997; 3 (8): 917-921.
47. Pennati M, Folini M, Zaffaroni N,. Targeting survivin in cancer therapy: Fulfilled promises and open questions. Carcinogenesis 2007; 28 (6): 1133-1139.
48. Kim SH, Singh SV,. p53-Independent apoptosis by benzyl isothiocyanate in human breast cancer cells is mediated by suppression of XIAP expression. Cancer Prev Res 2010; 3 (6): 718-726.